Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Human Reproduction (Oxford, England)|October 13, 2009
FOXL2 mutations lead to different ovarian phenotypes in BPES patients: Case ReportGéri Méduri, Anne Bachelot, Catherine Duflos, et al.
Bulletin Du Cancer|October 11, 2021
[Surgical de-escalation in gynecologic oncology]François Zaccarini, Claire Sanson, Amandine Maulard, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 12, 2025
Assessing the Status of Cyclin E1 (CCNE1) From Gene to Protein Level in Ovarian and Endometrial Carcinomas: A Systematic ReviewAlexis Trecourt, Catherine Genestie, Alexander Valent, et al.
Annals of Surgical Oncology|October 1, 2021
Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and ManagementGiulio Ricotta, Amandine Maulard, Massimo Candiani, et al.
Journal of Clinical Medicine|November 13, 2021
Cervical Cancer and Fertility-Sparing TreatmentFrançois Zaccarini, Claire Sanson, Amandine Maulard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2025
Prognosis of stage I ovarian mucinous tumors according to expansile and infiltrative typesMalek Bouhani, Stéphanie Schérier, Catherine Genestie, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic analysis of BRCA1-depleted cell line reveals a putative role for replication protein A2 up-regulation in BRCA1 breast tumor developmentJulien Bouley, Cédric Pionneau, Justine Varinot, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative TypeSebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Pageof 13